MD stock icon

Pediatrix Medical

12.72 USD
-0.01
0.08%
Updated Oct 22, 10:44 AM EDT
1 day
-0.08%
5 days
1.92%
1 month
21.37%
3 months
66.27%
6 months
40.86%
Year to date
35.61%
1 year
2.50%
5 years
-45.69%
 

About: Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.

Employees: 2,900

0
Funds holding %
of 6,740 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

237% more call options, than puts

Call options by funds: $165K | Put options by funds: $49K

47% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 34

8% more funds holding

Funds holding: 210 [Q1] → 226 (+16) [Q2]

1.27% more ownership

Funds ownership: 102.6% [Q1] → 103.86% (+1.27%) [Q2]

10% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 80

24% less capital invested

Capital invested by funds: $866M [Q1] → $659M (-$206M) [Q2]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$10
21%
downside
Avg. target
$11.88
7%
downside
High target
$14
10%
upside

4 analyst ratings

positive
25%
neutral
75%
negative
0%
Truist Securities
David Macdonald
78% 1-year accuracy
25 / 32 met price target
2%upside
$13
Hold
Maintained
7 Oct 2024
Jefferies
Jack Slevin
50% 1-year accuracy
1 / 2 met price target
10%upside
$14
Buy
Upgraded
26 Sept 2024
Truist Securities
David Macdonald
78% 1-year accuracy
25 / 32 met price target
21%downside
$10
Hold
Maintained
15 Aug 2024
UBS
A.J. Rice
89% 1-year accuracy
8 / 9 met price target
17%downside
$10.50
Neutral
Maintained
9 Aug 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™